Aldose reductase genotypes and cardiorenal complications: An 8-year prospective analysis of 1,074 type 2 diabetic patients

Diabetes Care

Volumn 31, Issue 11, 2008, Pages 2148-2153

  So, Wing Yee ^a   Wang, Ying ^a   Ng, Maggie C Y ^a   Yang, Xilin ^a   Ma, Ronald C W ^a   Lam, Vincent ^a   Kong, Alice P S ^a   Tong, Peter C Y ^a   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CAUSE OF DEATH; CHINESE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIALYSIS; DISEASE DURATION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HETEROZYGOTE; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RISK ASSESSMENT; ASIAN; CORONARY ARTERY DISEASE; ETHNOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HONG KONG; INCIDENCE; MIDDLE AGED;

AGED; ALDEHYDE REDUCTASE; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HONG KONG; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 59249086682     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0712     Document Type: Article

References (21)

1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCul- lough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154-2169, 2003
2. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63:225-232, 2003
3. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69-75, 1998
4. Schrijvers BF, De Vriese AS, Flyvbjerg A: From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cy- tokines. Endocr Rev 25:971-1010, 2004
5. Wang Y, Ng MCY, Lee SC, So WY, Tong CY, Cockram CS, Critchley JAJH, Chan JCN: Phenotypic heterogeneity associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care 26:2410-2415, 2003
6. Yang X, So WY, Tong PC, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong VC, Chan JC: Development and validation of an all-cause mortality risk score in type 2 diabetes. Arch Intern Med 168:451-457, 2008
7. Yang X, So WY, Kong AP, Ma RC, Ko GT, Ho CS, Lam CW, Cockram CS, Chan JC, Tong PC: Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. Am JCardiol 101: 596 -601, 2008
8. Yang XL, So WY, Kong AP, Ho CS, Lam CW, Ng MH, Lyu RR, Yin DD, Chow CC, Cockram CS, Tong PC, Chan JC: Modified end-stage renal disease risk score for Chinese type 2 diabetic patients: the Hong Kong Diabetes Registry. Diabetologia 50:1348-1350, 2007
9. Ma YC, Zuo L, Chen JH: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937-2944, 2006
10. Imperatore G, Knowler WC, Nelson RG, Hanson RL: Genetics of diabetic nephrop- athy in the Pima Indians. Curr Diab Rep 1:275-281, 2001
11. Kapor-Drezgic J, Zhou X, Babazono T, Dl- ugosz JA, Hohman T, Whiteside C: Effect of high glucose on mesangial cell protein ki- nase C-δ and -ε is polyol pathway-dependent. J Am Soc Nephrol 10:1193-1203, 1999
12. Morrish NJ, Wang S, Stevens LK, Fuller JH, Keen H: Mortality and causes of death in the WHO Multinational Survey of Vascular Diseases in Diabetes. Diabetologia 44:S14-S21, 2001
13. Tong PCY, Kong APS, So WY, Ng MHL, Yang XL, Ozaki R, Ma RCY, Lam CWK, Ho CS, Chow CC, Cockram CS, Chan JCN: Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes mellitus. Diabetes Care 29:2439-2444, 2006
14. So WY, KongAP, MaRC, OzakiR, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC: Glomerular filtration rate, cardiore- nal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 29:2046-2052, 2006
15. Bhatt D, Steg P, OhmanE, HirschA, Ikeda Y, Mas J, Goto S, Liau C, Richard A, Rother J, Wilson P, the REACH Registry Investigators: International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 11:180-189, 2006
16. Vikramadithyan RK, Hu Y, Noh HL, Liang CP, Hallam K, Tall AR, Ramasamy R, Goldberg IJ: Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Invest 115: 2434-2443, 2005
17. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
18. Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580-591, 2008
19. Shah VO, Scavini M, Nikolic J, Sun Y, Vai S, Griffith JK, Dorin RI, Stidley C, Yacoub M, Vander Jagt DL, Eaton RP, Zager PG: Z -2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab 83:2886-2891, 1998
20. Iso K, Tada H, Kuboki K, Inokuchi T: Long-term effect of epalrestat, an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in type 2 diabetic patients. J Diabetes Complications 15:241-244, 2001
21. Chan JCN, Wat NMS, So WY, Lam KSL, Chua CT, Wong TS, Morad Z, Dickson TZ, Hille D, Zhang Z, Cooper ME, Shahinfar S, Brenner BM, Kurokawa KA, the Asian RENAAL Study Investigators: RAAS blockade and renal disease in type 2 diabetic patients: an Asian perspective from the RENAAL Study. Diabetes Care 27: 874-879, 2004